Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, men seeking treatment for male pattern hair loss were highly concerned about their condition and had often attempted self-treatment, but many were dissatisfied with their physician consultations due to unmet expectations and perceived indifference from doctors.

This review discusses the medical and dental applications of polyhydroxyalkanoates (PHAs), highlighting their potential for improving drug delivery and providing biocompatible solutions for medical devices, but reports no new clinical results.

This review article summarizes the potential role of advanced medical therapies—using genes, cells, and/or tissue engineering—in treating various types of alopecia, by examining clinical research, basic studies, and ongoing trials.

This review explores cannabigerol (CBG) as a potential therapeutic agent with various pharmacological activities but reports no new clinical results, emphasizing the need for further research on its efficacy and safety.

This abstract explains that androgenetic alopecia, a common hair loss disorder influenced by genetics and hormones like dihydrotestosterone, has FDA-approved treatments including minoxidil, finasteride, and photolaser therapy, but its genetic basis and susceptibility to environmental factors remain complex.

This article discusses the ethical views of Polish physicians on performance-enhancing substances and emphasizes the need to improve their knowledge to better address related issues in their patients, but it reports no new results.

This study found that scalp medical tattooing effectively improved cosmetic appearance and concealed bifid parietal whorls without complications in the patients evaluated.

This study evaluated shaved style scalp medical tattoo (SMT) in individuals with advanced hair loss, reporting high patient and surgeon satisfaction scores.

This review reports that botulinum toxin is used in dermatology not only for treating rhytides but also for conditions like rosacea, hyperhidrosis, and menopause-related flushing, although its full safety and efficacy profile requires more research.

Korean medical treatments are effective for alopecia areata, especially in less severe cases.

This editorial reviews recent European legal developments related to patents on second medical uses and dosage regimes, with no new research findings reported.

The Ewha Medical Journal is now in PubMed, has an AI article editor, and offers Korean reporting guidelines.

This review discusses the varied symptoms and prevalence of long COVID in 20% to 60% of acute COVID-19 patients, emphasizing the lack of clear diagnostic criteria and treatment options, and proposes a functional medicine approach as a potential management strategy.

This study documented three cases of acute thallium poisoning—one involving accidental overdose and two linked to intentional homicide—characterized by neurological and systemic symptoms, and in severe instances, death, underscoring thallium compounds' significant toxicity.

This review discusses recent advancements in hair loss treatments, including stem cell and hair follicle cell therapies, growth factors, extracellular vesicles, gene therapy, and tissue engineering, highlighting their potential in improving hair regeneration and follicle health.

This study investigated hair enhancement treatments used by transgender men in the U.S. and found that while 90% used testosterone therapy, 44.1% sought additional facial hair enhancement options such as topical minoxidil, despite significant safety concerns reported by 77.3% of participants.

In this study, family history was identified as the most significant risk factor for premature hair graying among medical students at the University of Sumatera Utara.

This article discusses the involvement of Drs. Bessam Farjo, Nilofer Farjo, and Paul Kemp with HairClone Limited, but it reports no new research findings.

Online medical education helps doctors make better clinical decisions and increases their knowledge in treating fungal nail infections.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

This article discusses the impact of hair restoration surgery and the counselor's role in bridging communication between patient and doctor without presenting new research findings.

This correspondence discusses bias in expert medical testimony within workmen's compensation cases, emphasizing the author's objective approach, but provides no new empirical findings.

This study concluded that psychological well-being and self-image among Filipino males with androgenetic alopecia may be influenced by age, education level, and disease severity.

In this study, to address long wait times for alopecia specialists, researchers implemented shared medical appointments for women with female pattern hair loss, modeled on formats previously used for conditions like acne and vitiligo.

This abstract provides no results, as it only notes Sharon Keene's professional role and describes a non-blood test for AGA genetics.

This article reviews various medical treatments for hidradenitis suppurativa based on the author's experience with over 350 patients, but it reports no new clinical findings.

This review discusses female pattern hair loss, its psychological impact, and available treatments but provides no new clinical findings; the authors emphasize early intervention for better outcomes.

This study found that using medical terminology for newly medicalized disorders leads people to perceive them as more serious, more representative of a disease, and less common than when common language is used.

This review discusses current medical and surgical treatments for androgenetic alopecia, highlighting the use of finasteride and minoxidil for men and the role of hair transplantation techniques, without providing new clinical results.

This review summarizes various drug treatments for hidradenitis suppurativa, noting their effectiveness, side effects, and high recurrence rates, but reports no new clinical findings.